Table 1.
Number of endoscopic/microscopic studies | Number of endoscopic/microscopic patients | Endoscopic pooled proportion (95%CI) | I 2% (P value for heterogeneity) | Microscopic pooled proportion (95%CI) | I 2% (P value for heterogeneity) | P value for difference | |
---|---|---|---|---|---|---|---|
Patient characteristics | |||||||
Age | 11/5 | 1381/389 | 57.73 (51.35–56.10) | 0 (0.972) | 56.22 (54.07–58.37) | 0 (0.971) | 0.580 |
Males% | 19/5 | 3458/389 | 57 (54–60) | 62.8 (<0.001) | 63 (58–68) | 17.1 (0.305) | 0.024 |
Presenting symptoms | |||||||
Hypopituitarism% | 8/3 | 892/269 | 48 (28–68) | 97.9 (<0.001) | 23 (9–37) | 86.5 (0.001) | <0.001 |
Pre‐operative visual deficit% | 13/2 | 2200/226 | 57 (49–65) | 92.7 (<0.001) | 67.4 (0.080) | 44 (33–56) | <0.001 |
Tumour characteristics | |||||||
Macroadenoma% | 7/2 | 1030/167 | 86 (76–95) | 77.5 (0.012) | 63 (53–73) | 0 (<0.001) | <0.001 |
Superasellae invasion% | 4/1 | 967/144 | 53 (6–100) | 99.5 (<0.001) | 11 | NA | <0.001 |
Intrasellae/Clinvus invasion% | 3/1 | 476/144 | 55 (−20–131) | 99.5 (<0.001) | 12 | NA | <0.001 |
Knosp score 0–2% | 10/4 | 2216/354 | 45 (36–55) | 94.9 (<0.001) | 45 (29–60) | 89.4 (<0.001) | 0.979 |
Knosp score 3–4% | 10/4 | 2216/354 | 55 (45–64) | 94.9 (<0.001) | 55 (40–71) | 89.4 (<0.001) | 0.979 |
Maximum tumour diameter (mm) | 9/2 | 1576/226 | 27.15 (16.35–37.95) | 0 (0.971) | 27.65 (10.50–44.80) | 0 (0.868) | 0.548 |